This paper discusses the most significant aspects of secondary hypertension in older patients against the background of a rising proportion of elderly in the hypertensive population. Renal artery stenosis and pheochromocytoma are singled out as those causes of secondary hypertension which appear to be related to older age. The available data relevant to epidemiology of these conditions and age-dependent clinical charac-
Secondary forms of hypertension are rare in the general hypertensive population, their incidence usually being estimated at around 5%. Although rare in relative terms, in view of the high prevalence of hypertension, its secondary forms still account for a great number of cases who may benefit from specific, often curative treatment.
For that reason, the diagnosis (or exclusion) of secondary hypertension has been a continuing challenge to clinicians, aided by evolving laboratory methods and stimulated by the development and refinement of therapeutic modalities. The advance of modern methods of diagnosis and treatment has succeeded in improving prognosis for the individual patient with secondary hypertension, but at the same time brought to light such problems as the riskbenefit and cost-benefit ratios of the diagnostic procedures for the whole hypertensive population and the society at large.
Hypertension in the elderly should be viewed as an important clinical and epidemiological issue. Its weight is related to the rising proportion of elderly people in the developed societies and to age-dependence of cardiovascular diseases in general, and high blood pressure (BP) in particular.
Amongst the citizens of the United States 13% are older than 65 years. According to a prognosis, this proportion will rise to 21% by the year 2030. 1, 2 Recent data from Poland, whose population is stigmatised by excessive cardiovascular mortality, disclosed only a slightly lower proportion of citizens older than 65 years. 3 Contrary to past misunderstandings, it has now been well established that anti-hypertensive drug treatment in the elderly is beneficial, and hence, indicated. The meta-analysis of large trials of antihypertensive drug treatment in elderly hypertensives have demonstrated a 33%, 26% and 22%
Correspondence: Professor Włodzimierz Januszewicz, Klinika Nadciśnienia Te niczego, Centralny Szpital Kliniczny, 02 097 Warszawa, Banacha 1 a, Poland teristics are reviewed. Preservation of renal function in the elderly with renal artery stenosis is underlined as an important goal of therapy with revascularising techniques. It is proposed that screening for renal artery stenosis and pheochromocytoma may be equally important in the elderly as in the younger hypertensive patient.
reduction of cerebrovascular, coronary, and total cardiovascular mortality, respectively. 4 The practical care for the elderly hypertensive patient, now treated with hypotensive drugs with more conviction than ever, must take into account certain pathophysiological characteristics of old age which may influence the clinical symptomatology on the one hand, and the choice of treatment, on the other. The scope of this presentation allows us to mention only a few of these features, like the decreased arterial compliance and the preponderance of systolic hypertension, the blunted baroreceptor sensitivity with the resultant tendency to orthostatic BP fall, the decreasing renal blood flow and glomerular filtration rate (GFR), or altered drug metabolism. These characteristics, along with possible various coexistent diseases, especially generalised atherosclerosis, make the care of the elderly hypertensive a tedious and often expensive process, requiring a high degree of professional competence, occupying increasing time and attention of the medical practitioner.
Against this background we should now address the problem of secondary hypertension in the elderly focusing on those forms in which the cause of hypertension is amenable to specific or definitive therapy.
Several questions have to be addressed. Firstly, what is the incidence of these forms of hypertension in the older age groups? Second, can we identify distinct characteristics particular to secondary hypertension in the elderly which might have a bearing on the clinical course and therapeutic decisions? Finally, should the diagnostic approach differ from the general rules, hitherto concentrating on younger patients. We will confine our consideration to those forms of secondary hypertension which seem to have age-related distinctions, ie, renal artery stenosis and pheochromocytoma.
Renal artery stenosis is the most prevalent treatable cause of hypertension in general. It can be safely assumed that its prevalence increases with age in parallel with the prevalence of atherosclerosis.
However, reliable epidemiological information is lacking, although we know the age and genderrelated differences in the aetiology of renal artery stenosis, arterial dysplasia being characteristic of young patients, particularly women, and atherosclerosis being responsible for the stenosis in older patients, practically exclusively so in the truly elderly population. [5] [6] [7] [8] [9] To compensate for the obvious impossibility of carrying out a proper epidemiological study, various approaches have been used to determine the incidence of atherosclerotic renal artery stenosis, including clinical series, 9 autopsy studies 10,11 and reviews of aortograms performed for various indications. [12] [13] [14] The results of these studies give support to the initial assumption that the prevalence of renal artery stenosis over the age of 50 is higher than in the younger groups, rises further with age, and that generalised atherosclerosis is the important characteristic defining the probability of the diagnosis.
It should be noted in this context that several reports indicate that bilateral renal artery stenosis is distinctly more frequent in the older than in the younger patients, a likelihood of important impact on the diagnostic and therapeutic decisions. [15] [16] [17] [18] Considering the consequences of renovascular hypertension in the elderly, particular attention should be focused on renal function. In these patients ischaemic nephropathy develops in the aging kidney which often had been subject to longstanding essential hypertension preceding the development of the atherosclerotic lesion of the main renal artery, frequently bilateral. These circumstances make the elderly patient particularly vulnerable to renal failure. One study demonstrated that in 78% of patients aged 60 years or more with renal artery stenosis, serum creatinine was elevated. 15 Other authors report renal artery stenosis as a cause of terminal renal failure in 16% of their patients. 19 Amongst patients qualified for chronic dialysis by Scoble et al, 20 14% were those aged over 50 years with renal artery stenosis. 20 Studies on the natural history of the atherosclerotic renal artery stenosis indicate a generally progressive nature of the lesions. In five reports concerning 237 patients followed for 6 to 180 months the stenosis progressed in nearly 50% of cases, with complete occlusion of the artery in 14%. 21 However, individual variations were encountered, with both very rapid occlusion and a stable lesion. Interestingly, serum creatinine was a poor predictor of evolution of the stenosis, as was the degree of BP control. Another study in patients with stenoses less than 60% at the outset disclosed cumulative progression to more than 60% stenosis in 23% of cases at 1 year and in 42% at 2 years. 22 In the elderly hypertensive patient, generalised atherosclerosis is the most important feature influencing the diagnostic process, clinical course, therapeutic strategy and the outcome of therapy. Symptomatology suggestive of atherosclerotic lesions of any location should raise the suspicion of coexistent renal artery stenosis in a patient with hypertension; such a suspicion is particularly strong if an epigastric bruit is heard. In one study concerning 50 patients aged 65 years and older with documented renal artery stenosis exceeding 50%, ischaemic heart disease confirmed by cardiac catheterisation was present in 44% and the angiograms disclosed a significant narrowing of the carotid artery in 22%, while peripheral vascular disease was diagnosed in 72%. 16 Conversely, in 395 patients undergoing angiography for either suspected aortic and peripheral arterial disease, or renovascular disease, significant renal artery stenosis was found in 35% of those with abdominal aortic aneurysm, in 33% of cases of aorto-occlusive disease and in 39% of those with lower limb arterial occlusive lesions. 12 It is of note that in these three subgroups renal artery stenosis had not been suspected on clinical grounds. In a similar more recent study significant renal artery stenosis was found in 31% of patients whose angiograms disclosed abdominal or lower limb atherosclerosis. 23 On the other hand, these and other studies are a reminder that atherosclerotic renal artery stenosis may be present in normotensive patients, although its degree exceeding 50% is usually associated with hypertension.
Renal failure, diagnosed in an elderly hypertensive or normotensive patient presenting with signs of generalised atherosclerosis, developing in the course of anti-hypertensive drug treatment, is another important indication of a possible renal artery stenosis, especially if it supervenes in a patient receiving an angiotensin-converting enzyme (ACE) inhibitor. In this latter case it is strongly suggestive of bilateral lesion.
To highlight the characteristics of the elderly as opposed to the younger hypertensive patient, it can be proposed that generalised atherosclerosis calls for the diagnostic effort to seek for renal artery stenosis, and the propensity to renal failure justifies serious consideration of not only those therapeutic methods which provide a better control of hypertension, but also those which give a chance of kidney salvage through revascularisation.
To advocate an active, albeit careful diagnostic approach in the elderly hypertensive, a case should be made for the safety and efficacy of the ultimate interventions, including balloon angioplasty, arterial stenting and surgical repair of the arterial supply to the kidney, as opposed to the conservative drug treatment.
Balloon angioplasty, even if less successful in patients with atherosclerotic renal artery stenosis than in those with a dysplastic type of lesion, offers at least a fair chance of improved control of BP and preservation of renal function. This latter aspect may be particularly important in the elderly.
A relatively high rate of restenosis following balloon dilatation of the atherosclerotic renal artery stenosis, estimated in various reports at ෂ20% per year 7 may be eventually overcome with the advent of arterial stenting. However, caution should be applied in an over-enthusiastic approach to this latter method before the data from prospective trials are available.
Surgical intervention in the aged patient may carry an increased risk. Against this obvious fact stand the results of various studies demonstrating that in experienced hands the risk is quite acceptable and the results of surgical revascularisation procedures in carefully selected, but often complicated cases, may be very good, both for BP control and for renal salvage in particular. 16, 24 Thus it appears that a basic screening for renal artery stenosis should apply to all elderly hypertensive patients with generalised atherosclerosis, the latter characteristic being more important than the factual age. In addition to the usual clinical clues, renal ultrasonography seems to be a good, generally practicable basic first-step test. Demonstration of the asymmetry in kidney size should be viewed as suggestive of renal ischaemia. Further diagnostic tests should rely, where possible, on non-invasive procedures of which the duplex-Doppler scanning is especially advocated. It should be pointed out that angiography may carry an increased risk in the patient with widespread arterial lesions, and yet it will eventually concern mostly the patients with generalised atherosclerosis. In carefully selected patients angiographic examinations will be required for the definite diagnosis of renal artery stenosis and for consideration of angioplasty, stenting or surgical revascularisation. Moreover, it will often be necessary to obtain images of the extrarenal arterial tree to ascertain the indications to, and the sequence of, interventions correcting arterial narrowing at other sites.
Pheochromocytoma is a rare cause of hypertension, its incidence being usually estimated at around 0.1% of the hypertensive population. Although the disease is rare, its proper diagnosis is very important at any age because of possible life-threatening sequelae which may be prevented by surgery. The case reports of pheochromocytoma in older patients are scarce and it appears that there prevails a feeling that the disease rarely affects the elderly. However, analysis of the studies based on larger cohorts of patients points to the contrary. In our own clinical series of 155 patients, 9% were aged more than 60 years. In other groups of patients, age 60 years or more was reported in 11%, 12%, 26% and 27%. 9, [25] [26] [27] Swedish data based on a cohort combining 439 clinical and autopsy cases have shown that 65% of the autopsy subjects were aged 60 years or more. 28 The mean age of the clinically diagnosed cases was lower than that of those diagnosed at autopsy (49 vs 66 years), and it was estimated that the incidence of pheochromocytoma per 1 million of population in Sweden was agedependent and at the age of 80 years or more it was twice as high as at the age of 50-59 years. A similar incidence in relation to age was reported from Australia. 27 Also, other reports based on smaller groups of patients have demonstrated that clinically unsuspected pheochromocytoma found at autopsy or during laparotomy, as well as following imaging examinations of the abdomen for unrelated indications, often concern elderly patients. 29, 30 This suggests that in the older patient pheochromocytoma may run a silent clinical course more readily than in the younger. The significance of these findings is not obvious. It would not be prudent to presume that the elderly patients do not demonstrate the effects of excess catecholamines due to diminished sensitivity, since the converse is also true. The increased prevalence of ischaemic heart disease and generalised vascular pathology makes these patients particularly vulnerable to consequences of catecholamine surges. Age-dependent modification of catecholamine metabolism within the tumour might explain the dilemma in some cases. It is of note that in our series, the older patients with pheochromocytoma displayed lower ratios of urinary noradrenaline to the sum of metoxycatecholamines when compared to the younger subgroups, a finding consistent with such an assumption, but in this report concerning clinically diagnosed cases.
Considering the cases diagnosed incidentally during autopsy, it would be difficult to ascertain ex-post their functional state ante mortem and hence the chance of biochemical diagnosis during life. However, it must be concluded that pheochromocytoma does occur in the elderly patient as likely as in the younger one and must not be missed during differential diagnosis. Moreover it might be advisable to look out for atypical clinical presentation including normal BP warranting at least the basic biochemical screening. These precautions are fully justified because even quite elderly patients with pheochromocytoma may benefit from surgical treatment.
